Clinical trial
Amisulpride in Schizophrenic Patients
NCT00331981 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00331981 |
|---|---|
| Title | Amisulpride in Schizophrenic Patients |
| Official title | Study of the Efficacy and Safety After Long-Term Treatment With Amisulpride in Schizophrenic Patients |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Amisulpride |
| Enrollment | 138 |
| Start date | Feb 1, 2004 |
| First posted | May 31, 2006 |
| Last update posted | Apr 10, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: